# Commission Delegated Regulation (EU) 2020/689 of 17 December 2019 supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council as regards rules for surveillance, eradication programmes, and disease-free status for certain listed and emerging diseases (Text with EEA relevance), Article 80: Special provisions for compartments which comprise individual establishments which commence or recommence aquaculture activities and where the health status regarding a specific disease is independent of the health status of the surrounding natural waters

Extent: E+W+S+N.I.

1. A new establishment which is to commence aquaculture activities is considered to be disease-free when:
(a) it complies with point (a) of paragraph 2 and paragraphs 3 to 5 of Article 79; and
(b) it commences aquaculture activities with aquaculture animals from a disease-free Member State, zone or compartment.
2. An establishment which recommences aquaculture activities after a break and complies with paragraph 1 is considered to be disease-free without the surveillance referred to in point (a)(ii) of Article 73(1) provided:
(a) the health history of the establishment is known to the competent authority and there has been no confirmation in the establishment of a category B or category C disease;
(b) the establishment is cleaned, disinfected and fallowed, if necessary, prior to repopulation.
3. An establishment which recommences its activities after the confirmation of a category B or category C disease is considered to be disease-free from the confirmed disease, provided:
(a) a representative sample of the animals which have been repopulated into the establishment from a disease-free Member State, zone or compartment following cleaning, disinfection and fallowing is tested for the relevant disease no sooner than 3 months and no later than 12 months after they have been exposed to conditions including water temperature, which are conducive to clinical expression of the disease;
(b) the sampling and diagnostic tests set out in the relevant Chapter of Part II of Annex VI are used and samples are taken from the number of animals that will ensure the detection of the relevant disease with a 95 % confidence if the targeted prevalence is 2 %;
(c) results of the testing described in point (b) are negative.

---
Source: https://www.legislation.gov.uk/eur/2020/689/article/80 (the official version)
Page: https://openlegislation.uk/eu-regulation-2020-689/article-80
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.